Richard C. Woodman
Director/Board Member at H3 Biomedicine, Inc.
Profile
Richard C.
Woodman is currently the Director at H3 Biomedicine, Inc. He previously worked as the Senior Director-Medical at Johnson & Johnson from 2002 to 2006, and as the Head-US Oncology Clinical Development at Novartis, Inc. from 2006 to 2018.
He also served as the Chief Clinical Officer-Oncology Business Group at Eisai Co., Ltd.
and as the Chief Medical Officer, SVP-Research & Development at Onconova Therapeutics, Inc. from 2018 to 2021.
Prior to his industry career, he was a Professor at the University of Calgary.
Woodman received his undergraduate degree from the University of British Columbia and his doctorate from the University of Calgary in 1981.
Richard C. Woodman active positions
Companies | Position | Start |
---|---|---|
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The private company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Director/Board Member | 2022-01-10 |
Former positions of Richard C. Woodman
Companies | Position | End |
---|---|---|
TRAWS PHARMA, INC. | Chief Tech/Sci/R&D Officer | 2021-01-14 |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Chief Tech/Sci/R&D Officer | 2018-02-28 |
JOHNSON & JOHNSON | Corporate Officer/Principal | 2005-12-31 |
EISAI CO., LTD. | Corporate Officer/Principal | - |
University of Calgary | Corporate Officer/Principal | - |
Training of Richard C. Woodman
University of British Columbia | Undergraduate Degree |
University of Calgary | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
JOHNSON & JOHNSON | Health Technology |
EISAI CO., LTD. | Health Technology |
TRAWS PHARMA, INC. | Health Technology |
Private companies | 2 |
---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Health Technology |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The private company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Health Technology |
- Stock Market
- Insiders
- Richard C. Woodman